Navigation Links
New, Larger, Bilateral Breast Graft Kits Announced by MTF
Date:1/4/2012

EDISON, N.J., Jan. 4, 2012 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has announced the release of two new sizes of its popular FLEX HD® bi-lateral breast kits. The new sizes--16cm x 20cm and 20cm x 20cm--are being introduced in order to meet the needs of surgeons and their patients. This unique human dermal allograft is specifically prepared and packaged for bilateral breast reconstruction.

It has been a year since MTF introduced its bi-lateral breast kit for the first time.  The new, larger sizes are being released based on surgeon input to accommodate the need for larger tissue coverage that may be called for depending on implant and patient considerations. 

The use of human acellular dermal matrix (ADM) grafts in breast reconstruction is becoming increasingly popular.  Since many breast cases are bilateral, and aesthetic outcomes are desired, surgeons asked MTF for procedure-based kits containing two matched pieces of FlexHD acellular hydrated dermal tissue, prepared from the same donor.

FlexHD grafts offer excellent handling characteristics and biomechanical properties as well as the added benefit of convenience.  They are packaged hydrated and do not require hydration prior to use or refrigeration for storage, resulting in tissue grafts that are easily accessible and ready to use at all times.

FlexHD grafts help to avoid potentially costly and unnecessary work prior to and during cases.  Surgeons may select the size and type of graft they'd like to use any time during a procedure, preventing any of the costs associated with wasted tissue or added OR time.

FlexHD passes USP <71> sterility tests and meets or exceeds FDA and AATB standards for donor criteria, processing and tissue safety. With over 4.8 million grafts distributed since its inception, MTF possesses an unrivaled safety record.

To inquire about these new breast kits contact MTF customer service at 1-800-433-6576.

The Musculoskeletal Transplant Foundation, a non-profit organization, is the nation's leading tissue bank. The Foundation is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations.  Since its inception in 1987, MTF has received tissue from close to 90,000 donors and distributed almost five million grafts for transplantation.

For information:
Cindy Gordon, Insight Communication
609.252.1300


'/>"/>
SOURCE The Musculoskeletal Transplant Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bilateral DePuy Hip Implant Failures Lead to Lawsuit
2. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
3. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
4. Diablo Valley Oncology Performs Breast Intraoperative Radiation Procedure - First in the East Bay
5. Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium
6. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
7. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
8. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
9. MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium
10. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
11. Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Frontier Pharma: Chronic Obstructive Pulmonary ... Chronic Obstructive Pulmonary Disease (COPD) ... of the airways and lungs. Persistent breathing difficulties ... disease one of the leading causes of morbidity ... world. COPD is linked to cumulative exposure to ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
Breaking Medicine Technology:
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... the ability to correct pelvic organ prolapse with the latest techniques and the ... at greatest risk for pelvic organ prolapse, particularly after menopause. Other risk factors ...
(Date:2/7/2016)... ... 2016 , ... HealthSmart Holdings, Inc. announced today the launch ... and information to lower the costs, and increase the impact of their healthcare ... healthcare benefits by as much as 22%:, + Price and quality transparency, ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... , ... February 06, 2016 , ... With the ... add warm color grades to their footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. By manipulating each pixel, LUT's can ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):